Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
LMAT Lemaitre Vascular Inc
- Stocks
- Healthcare
- NASDAQ: LMAT
Price (delayed)
$80.26
Market cap
$1.81B
P/E Ratio
40.95
Dividend/share
$0.68
EPS
$1.96
Enterprise value
$1.97B
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops,
Highlights
LMAT's quick ratio has soared by 147% YoY and by 102% QoQ
LMAT's net income is up by 46% year-on-year and by 7% since the previous quarter
Key stats
What are the main financial stats of LMAT
Market
Valuations
Earnings
Shares outstanding
22.56M
Market cap
$1.81B
Enterprise value
$1.97B
Price to earnings (P/E)
40.95
Price to book (P/B)
5.35
Price to sales (P/S)
8.2
EV/EBIT
34.52
EV/EBITDA
29.52
EV/Sales
8.96
Revenue
$219.86M
Gross profit
$150.9M
Operating income
$52.26M
Net income
$44.04M
EBIT
$57.08M
EBITDA
$66.75M
Free cash flow
$37.16M
Per share
Balance sheet
Liquidity
EPS
$1.96
EPS diluted
$1.93
Free cash flow per share
$1.66
Book value per share
$15
Revenue per share
$9.79
TBVPS
$20.05
Total assets
$551.82M
Total liabilities
$214.53M
Debt
$185.69M
Equity
$337.29M
Working capital
$371.59M
Debt to equity
0.55
Current ratio
13.14
Quick ratio
10.77
Net debt/EBITDA
2.4
Margins
Efficiency
Dividend
EBITDA margin
30.4%
Gross margin
68.6%
Net margin
20%
Operating margin
23.8%
Return on assets
10.7%
Return on equity
13.6%
Return on invested capital
18.1%
Return on capital employed
11%
Return on sales
26%
Dividend yield
0.85%
DPS
$0.68
Payout ratio
34.7%
LMAT stock price
How has the Lemaitre Vascular stock price performed over time
Intraday
-1.52%
1 week
1.98%
1 month
-4.34%
1 year
5.61%
YTD
-12.89%
QTD
-4.34%
Financial performance
How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$219.86M
Gross profit
$150.9M
Operating income
$52.26M
Net income
$44.04M
Gross margin
68.6%
Net margin
20%
LMAT's net income is up by 46% year-on-year and by 7% since the previous quarter
The operating income has grown by 42% YoY and by 5% from the previous quarter
The company's net margin rose by 28% YoY and by 3.1% QoQ
The company's operating margin rose by 25% YoY and by 2.1% QoQ
Price vs fundamentals
How does LMAT's price correlate with its fundamentals
Growth
What is Lemaitre Vascular's growth rate over time
Valuation
What is Lemaitre Vascular stock price valuation
P/E
40.95
P/B
5.35
P/S
8.2
EV/EBIT
34.52
EV/EBITDA
29.52
EV/Sales
8.96
The EPS has grown by 44% YoY and by 5% from the previous quarter
The P/E is 13% less than the last 4 quarters average of 47.2 and 8% less than the 5-year quarterly average of 44.3
The equity has grown by 13% YoY
LMAT's price to book (P/B) is 11% higher than its 5-year quarterly average of 4.8 but 8% lower than its last 4 quarters average of 5.8
The P/S is 14% above the 5-year quarterly average of 7.2 but 8% below the last 4 quarters average of 8.9
Lemaitre Vascular's revenue has increased by 14% YoY and by 3.2% from the previous quarter
Efficiency
How efficient is Lemaitre Vascular business performance
The ROE has grown by 30% YoY and by 3.8% from the previous quarter
The ROS has grown by 27% YoY and by 2.4% from the previous quarter
LMAT's ROIC is down by 26% since the previous quarter and by 12% year-on-year
Lemaitre Vascular's return on assets has increased by 18% YoY but it has decreased by 7% QoQ
Dividends
What is LMAT's dividend history
DPS
$0.68
Dividend yield
0.85%
Payout ratio
34.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Lemaitre Vascular financials performed over time
The company's total assets is 157% higher than its total liabilities
LMAT's quick ratio has soared by 147% YoY and by 102% QoQ
Lemaitre Vascular's current ratio has soared by 102% YoY and by 70% from the previous quarter
The company's debt is 45% lower than its equity
The equity has grown by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.